| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/11/2001 | CA2403537A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 10/11/2001 | CA2402586A1 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 10/11/2001 | CA2402416A1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 10/11/2001 | CA2401948A1 Cd20/ige-receptor like molecules and uses thereof |
| 10/11/2001 | CA2401854A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 10/11/2001 | CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | CA2397203A1 Phosphoramidate prodrugs |
| 10/11/2001 | CA2388673A1 Protein having activity as an angiogenesis modulator |
| 10/11/2001 | CA2341786A1 Truncated reelin protein and dna encoding the same |
| 10/10/2001 | EP1143253A1 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 10/10/2001 | EP1143007A1 Ucp-2 promoter and use thereof |
| 10/10/2001 | EP1143004A2 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
| 10/10/2001 | EP1143001A1 Novel interferon-alpha |
| 10/10/2001 | EP1143000A1 Screening method |
| 10/10/2001 | EP1142999A1 Novel protein and dna thereof |
| 10/10/2001 | EP1142993A1 Novel serine protease bssp5 |
| 10/10/2001 | EP1142910A1 Inhibitors for the formation of soluble human CD23 |
| 10/10/2001 | EP1142908A1 Process for producing activated protein |
| 10/10/2001 | EP1142907A1 THE POLYPEPTIDE DREAM, USED AS Ca2+ IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR |
| 10/10/2001 | EP1142905A1 Novel depsipeptide compound |
| 10/10/2001 | EP1142904A1 Sponge protein hydrolysates and methods of producing the same |
| 10/10/2001 | EP1142590A1 Gene therapy for diabetic ischemic disease |
| 10/10/2001 | EP1142583A1 Antitumor agents |
| 10/10/2001 | EP1142582A1 Use of FSH for treating infertility |
| 10/10/2001 | EP1142581A2 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 10/10/2001 | EP1142580A1 Use of peptide |
| 10/10/2001 | EP1142579A2 Bone resorption inhibitors |
| 10/10/2001 | EP1142569A2 Coating of small particles |
| 10/10/2001 | EP1142568A1 Pharmaceutical compositions containing cyclosporins |
| 10/10/2001 | EP1142566A1 Compositions for ophtalmic use containing cyclosporin, hyaluronic acid and polysorbate |
| 10/10/2001 | EP1141407A2 Method of identifying a psychotropic agent using differential gene expression |
| 10/10/2001 | EP1141376A1 Peptidoglycan recognition proteins |
| 10/10/2001 | EP1141365A1 Method for preparing suspension of stable posiplexes |
| 10/10/2001 | EP1141353A2 Plant cell cycle genes and uses thereof |
| 10/10/2001 | EP1141343A1 Non-viral transfection vector |
| 10/10/2001 | EP1141338A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 10/10/2001 | EP1141334A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 10/10/2001 | EP1141332A1 Human cyclic nucleotide pdes |
| 10/10/2001 | EP1141331A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 10/10/2001 | EP1141326A2 Human akt-3 |
| 10/10/2001 | EP1141318A2 P450 / acetaminophen gdept for cancer treatment |
| 10/10/2001 | EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 10/10/2001 | EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 10/10/2001 | EP1141311A1 Protective antigen of group a streptococci (spa) |
| 10/10/2001 | EP1141306A2 Streptococcus antigens |
| 10/10/2001 | EP1141305A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 10/10/2001 | EP1141300A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 10/10/2001 | EP1141297A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses |
| 10/10/2001 | EP1141296A2 Interferon-epsilon |
| 10/10/2001 | EP1141295A1 Human chemokine beta-10 mutant polypeptides |
| 10/10/2001 | EP1141294A1 Method of enhancing the biological activity of ligands |
| 10/10/2001 | EP1141293A2 Vascular endothelial growth factor-x |
| 10/10/2001 | EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 10/10/2001 | EP1141288A2 Lymphocytic membrane proteins |
| 10/10/2001 | EP1141287A1 Pancreatic polypeptide zsig66 |
| 10/10/2001 | EP1141286A1 Cytokine receptor chain |
| 10/10/2001 | EP1141284A2 Methods and compositions for inhibiting neoplastic cell growth |
| 10/10/2001 | EP1141283A1 Member of the tnf ligand family |
| 10/10/2001 | EP1141282A2 Human anion transporter genes atnov |
| 10/10/2001 | EP1141279A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 10/10/2001 | EP1141277A2 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells |
| 10/10/2001 | EP1141276A2 Novel polypeptides and nucleic acids encoding same |
| 10/10/2001 | EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy |
| 10/10/2001 | EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF |
| 10/10/2001 | EP1141267A1 Secreted proteins |
| 10/10/2001 | EP1141252A2 Human desaturase gene and uses thereof |
| 10/10/2001 | EP1141248A2 A METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-$g(b) RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 10/10/2001 | EP1141247A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 10/10/2001 | EP1141245A1 Somatic cells with ablated prp gene and methods of use |
| 10/10/2001 | EP1141243A2 Methods of immunosuppression |
| 10/10/2001 | EP1141240A1 Use of cd40 engagement to alter t cell receptor usage |
| 10/10/2001 | EP1141079A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties |
| 10/10/2001 | EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 10/10/2001 | EP1141024A2 Polypeptide variants with altered effector function |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1141022A1 Serine protease inhibitor |
| 10/10/2001 | EP1141018A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 10/10/2001 | EP1141017A2 Characterization of the soc/crac calcium channel protein family |
| 10/10/2001 | EP1141016A1 Three dimensional structure of a sterile alpha motif domain |
| 10/10/2001 | EP1141015A1 Insulin-like growth factor (igf) i mutant variants |
| 10/10/2001 | EP1141014A1 Insulin-like growth factor (igf) i mutant variants |
| 10/10/2001 | EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 10/10/2001 | EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response |
| 10/10/2001 | EP1141009A2 Reagents and methods useful for detecting diseases of the breast |
| 10/10/2001 | EP1141008A1 Class ii cytokine receptor-like proteins and nucleic acids encoding them |
| 10/10/2001 | EP1141006A1 Topoisomerase ii inhibitor |
| 10/10/2001 | EP1141005A1 Hypoxia-inducible factor 1alpha hif-1alpha variants and methods for identifying hif-1alpha modulators |
| 10/10/2001 | EP1141000A1 Superantigens |
| 10/10/2001 | EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140997A2 Chlamydia trachomatis antigens |
| 10/10/2001 | EP1140995A2 Peptides for inhibiting hbv core proteins |
| 10/10/2001 | EP1140994A1 Outer surface proteins, their genes, and their use |
| 10/10/2001 | EP1140993A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 10/10/2001 | EP1140992A1 Cyclic peptide antifungal agents having a sugar substituent |
| 10/10/2001 | EP1140991A1 Cyclic peptide antifungal agents |
| 10/10/2001 | EP1140990A1 Penicillins as pharmaceuticals for the downregulation of ifn gamma production |
| 10/10/2001 | EP1140989A1 Alpha(v) beta(6) integrin inhibitors |
| 10/10/2001 | EP1140988A1 Halovir, an antiviral marine natural product, and derivatives thereof |
| 10/10/2001 | EP1140987A1 Peptides for inhibiting hpv e6 proteins |